ST Germain D J Co. Inc. lifted its stake in McKesson Co. (NYSE:MCK – Free Report) by 350.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and ...

McKesson (NYSE:MCK – Get Free Report) had its price objective cut by Citigroup from $713.00 to $677.00 in a research note ...

Cardinal Health’s profit margin lags behind peers, impacting growth. See why CAH stock’s outlook may be hindered by legal ...

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson (MCK – Research Report), with a price target of ...

McKesson (MCK) concluded the recent trading session at $585.24, signifying a +0.83% move from its prior day's close.

Kairos Pharma Ltd. , a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, and Neil Bhowmick, Chief Scientific Officer, will present a corporate ...

Pro-Dex, Inc. PDEX has witnessed rapid growth over the past year. The company’s valuation has grown tremendously over the ...

IndustryFuture Market Insights’ latest report on the electronic medical record (EMR) ecosystem identifies significant growth opportunities, projecting the market to achieve a valuation of USD 18.82 ...

Irving-based McKesson Corp. has finalized the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity ...